Optima Medical Innovations Corp. (OMIC)

Feb 21, 2025 - OMIC was delisted (reason: acquired by Deerfield)
20.01
0.00 (0.00%)
Inactive · Last trade price on Feb 20, 2025
Market Cap48.00
Revenue (ttm)1.94M -72.9%
Net Income-365,340
EPS-0.01
Shares Out n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume7,908
Open20.00
Previous Close20.01
Day's Range20.00 - 20.01
52-Week Range5.34 - 23.41
Beta1.84
AnalystsHold
Price Targetn/a
Earnings DateMar 17, 2025

About OMIC

Optima Medical Innovations Corp. delivers pathways to innovative, science-based health, and wellness solutions. It offers solution for pain relief, wellness, and cancer therapy. The company was formerly known as Tree of Knowledge International Corp. and changed its name to Optima Medical Innovations Corp. in November 2021. Optima Medical Innovations Corp. is based in Toronto, Canada.

Sector Healthcare
IPO Date May 27, 2021
Employees 255
Stock Exchange NASDAQ
Ticker Symbol OMIC
Full Company Profile

Financial Performance

In 2020, Singular Genomics Systems's revenue was $4.61 million, a decrease of -14.09% compared to the previous year's $5.37 million. Losses were -$3.96 million, -77.53% less than in 2019.

Financial Statements

News

Singular Genomics Announces Closing of Acquisition by Deerfield Management

SAN DIEGO, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower ...

1 year ago - GlobeNewsWire

Investors With Losses Are Invited To Join The Schall Law Firm In An Investigation Into Singular Genomics Systems, Inc. For Securities Fraud

LOS ANGELES, CA / ACCESS Newswire / January 30, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Singular ...

1 year ago - Accesswire

Investors With Losses Are Invited To Join The Schall Law Firm In An Inquiry Into Singular Genomics Systems, Inc. For Securities Fraud

LOS ANGELES, CA / ACCESS Newswire / January 28, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Singular ...

1 year ago - Accesswire

OMIC Investors Have the Opportunity to Join Investigation of Singular Genomics Systems, Inc. with the Schall Law Firm

LOS ANGELES , Jan. 28, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Singular Genomics Sy...

1 year ago - PRNewsWire

Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Singular Genomics Systems, Inc. For Securities Fraud

LOS ANGELES, CA / ACCESS Newswire / January 26, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Singular ...

1 year ago - Accesswire

SINGULAR GENOMICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Singular Genomics Systems, Inc. - OMIC

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Singular Genomic...

1 year ago - Business Wire

Singular Genomics Enters into Agreement to be Acquired by Deerfield for $20.00 in Cash per Share

SAN DIEGO, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC) (“Singular Genomics” or the “Company”), a company leveraging novel next-generation sequencing (NGS) and spat...

1 year ago - GlobeNewsWire

Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital

SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower...

1 year ago - GlobeNewsWire

$1.8M Bet On Singular Genomics? Check Out These 3 Stocks Executives Are Buying

Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.

Other symbols: NEWTSRBK
1 year ago - Benzinga

Singular Genomics Receives Non-Binding Acquisition Proposal from Deerfield

SAN DIEGO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower...

1 year ago - GlobeNewsWire

Singular Genomics to Report Second Quarter 2024 Financial Results on August 13, 2024

SAN DIEGO, July 30, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower ...

1 year ago - GlobeNewsWire

Singular Genomics Regains Compliance with Nasdaq Minimum Bid Price Requirement

SAN DIEGO, July 15, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower ...

1 year ago - GlobeNewsWire

Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday

With U.S. stock futures trading slightly higher this morning on Monday, some of the stocks that may grab investor focus today are as follows:

Other symbols: EPACITISTOKXAIR
1 year ago - Benzinga

Singular Genomics Announces 1-for-30 Reverse Stock Split

SAN DIEGO, June 21, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower ...

1 year ago - GlobeNewsWire

Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference

SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower r...

1 year ago - GlobeNewsWire

Singular Genomics Reports Recent Highlights and First Quarter 2024 Financial Results

SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower r...

2 years ago - GlobeNewsWire

Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results

SAN DIEGO, March 18, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower...

2 years ago - GlobeNewsWire

Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024

SAN DIEGO, March 04, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researc...

2 years ago - GlobeNewsWire

Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing Platform

SAN DIEGO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower ...

2 years ago - GlobeNewsWire

Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis

SAN DIEGO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower ...

2 years ago - GlobeNewsWire

Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue

SAN DIEGO, Jan. 07, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower research...

2 years ago - GlobeNewsWire

Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial Results

SAN DIEGO, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower research...

2 years ago - GlobeNewsWire

Singular Genomics to Report Third Quarter 2023 Financial Results on November 14, 2023

SAN DIEGO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower research...

2 years ago - GlobeNewsWire

Singular Genomics to Present at the Gilmartin Group Emerging Growth Company Showcase

SAN DIEGO, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researc...

2 years ago - GlobeNewsWire

Top 5 Health Care Stocks That May Explode In Q3 - BioVie (NASDAQ:BIVI), Galera Therapeutics (NASDAQ:GRTX)

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Other symbols: BIVIISPC
2 years ago - Benzinga